Logo image of BIM.PA

BIOMERIEUX (BIM.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:BIM - FR0013280286 - Common Stock

110.3 EUR
+0.2 (+0.18%)
Last: 12/31/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, BIM scores 6 out of 10 in our fundamental rating. BIM was compared to 62 industry peers in the Health Care Equipment & Supplies industry. BIM is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BIM has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BIM was profitable.
BIM had a positive operating cash flow in the past year.
Each year in the past 5 years BIM has been profitable.
BIM had a positive operating cash flow in each of the past 5 years.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

With an excellent Return On Assets value of 7.04%, BIM belongs to the best of the industry, outperforming 80.65% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.61%, BIM is in the better half of the industry, outperforming 64.52% of the companies in the same industry.
BIM's Return On Invested Capital of 8.55% is fine compared to the rest of the industry. BIM outperforms 75.81% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BIM is in line with the industry average of 9.74%.
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROIC 8.55%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

BIM has a Profit Margin of 9.17%. This is in the better half of the industry: BIM outperforms 66.13% of its industry peers.
BIM's Profit Margin has been stable in the last couple of years.
BIM has a Operating Margin of 12.37%. This is comparable to the rest of the industry: BIM outperforms 58.06% of its industry peers.
In the last couple of years the Operating Margin of BIM has grown nicely.
Looking at the Gross Margin, with a value of 56.27%, BIM is in line with its industry, outperforming 53.23% of the companies in the same industry.
BIM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.37%
PM (TTM) 9.17%
GM 56.27%
OM growth 3Y-12.85%
OM growth 5Y2.1%
PM growth 3Y-15.21%
PM growth 5Y1.25%
GM growth 3Y-2.07%
GM growth 5Y0.3%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

BIM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, BIM has about the same amount of shares outstanding.
Compared to 5 years ago, BIM has less shares outstanding
The debt/assets ratio for BIM has been reduced compared to a year ago.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

BIM has an Altman-Z score of 6.87. This indicates that BIM is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BIM (6.87) is better than 91.94% of its industry peers.
The Debt to FCF ratio of BIM is 1.15, which is an excellent value as it means it would take BIM, only 1.15 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.15, BIM belongs to the best of the industry, outperforming 85.48% of the companies in the same industry.
A Debt/Equity ratio of 0.09 indicates that BIM is not too dependend on debt financing.
BIM has a Debt to Equity ratio of 0.09. This is in the better half of the industry: BIM outperforms 79.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Altman-Z 6.87
ROIC/WACC1.08
WACC7.92%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

BIM has a Current Ratio of 2.27. This indicates that BIM is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.27, BIM is in the better half of the industry, outperforming 64.52% of the companies in the same industry.
A Quick Ratio of 1.30 indicates that BIM should not have too much problems paying its short term obligations.
The Quick ratio of BIM (1.30) is better than 61.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.3
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

The earnings per share for BIM have decreased by -8.57% in the last year.
The Earnings Per Share has been growing by 10.91% on average over the past years. This is quite good.
BIM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.28%.
BIM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.27% yearly.
EPS 1Y (TTM)-8.57%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%

3.2 Future

The Earnings Per Share is expected to grow by 12.12% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.02% on average over the next years.
EPS Next Y16.45%
EPS Next 2Y14.56%
EPS Next 3Y13.42%
EPS Next 5Y12.12%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y6.02%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 28.58, BIM can be considered very expensive at the moment.
62.90% of the companies in the same industry are more expensive than BIM, based on the Price/Earnings ratio.
BIM is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 21.77, which indicates a rather expensive current valuation of BIM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BIM is on the same level as its industry peers.
BIM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.13.
Industry RankSector Rank
PE 28.58
Fwd PE 21.77
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

69.35% of the companies in the same industry are more expensive than BIM, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, BIM is valued a bit cheaper than the industry average as 66.13% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 29.74
EV/EBITDA 13.36
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of BIM may justify a higher PE ratio.
A more expensive valuation may be justified as BIM's earnings are expected to grow with 13.42% in the coming years.
PEG (NY)1.74
PEG (5Y)2.62
EPS Next 2Y14.56%
EPS Next 3Y13.42%

3

5. Dividend

5.1 Amount

BIM has a yearly dividend return of 0.82%, which is pretty low.
BIM's Dividend Yield is comparable with the industry average which is at 1.11.
With a Dividend Yield of 0.82, BIM pays less dividend than the S&P500 average, which is at 2.00.
Industry RankSector Rank
Dividend Yield 0.82%

5.2 History

On average, the dividend of BIM grows each year by 19.36%, which is quite nice.
Dividend Growth(5Y)19.36%
Div Incr Years1
Div Non Decr Years7
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BIM pays out 28.04% of its income as dividend. This is a sustainable payout ratio.
BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.04%
EPS Next 2Y14.56%
EPS Next 3Y13.42%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIOMERIEUX

EPA:BIM (12/31/2025, 7:00:00 PM)

110.3

+0.2 (+0.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04
Earnings (Next)03-05 2026-03-05/amc
Inst Owners21.44%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap13.06B
Revenue(TTM)4.12B
Net Income(TTM)378.00M
Analysts74.12
Price Target128.35 (16.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.82%
Yearly Dividend0.85
Dividend Growth(5Y)19.36%
DP28.04%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.62%
PT rev (3m)0.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.53%
EPS NY rev (3m)-2.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.62%
Revenue NY rev (3m)-1.01%
Valuation
Industry RankSector Rank
PE 28.58
Fwd PE 21.77
P/S 3.17
P/FCF 29.74
P/OCF 16.57
P/B 3.32
P/tB 4.67
EV/EBITDA 13.36
EPS(TTM)3.86
EY3.5%
EPS(NY)5.07
Fwd EY4.59%
FCF(TTM)3.71
FCFY3.36%
OCF(TTM)6.66
OCFY6.04%
SpS34.82
BVpS33.24
TBVpS23.61
PEG (NY)1.74
PEG (5Y)2.62
Graham Number53.73
Profitability
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROCE 11.69%
ROIC 8.55%
ROICexc 9.37%
ROICexgc 13.09%
OM 12.37%
PM (TTM) 9.17%
GM 56.27%
FCFM 10.65%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.11%
ROCE(3y)13.72%
ROCE(5y)16.21%
ROICexgc growth 3Y-22.61%
ROICexgc growth 5Y-8.16%
ROICexc growth 3Y-19.09%
ROICexc growth 5Y-1.65%
OM growth 3Y-12.85%
OM growth 5Y2.1%
PM growth 3Y-15.21%
PM growth 5Y1.25%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Debt/EBITDA 0.36
Cap/Depr 73.47%
Cap/Sales 8.47%
Interest Coverage 250
Cash Conversion 80%
Profit Quality 116.14%
Current Ratio 2.27
Quick Ratio 1.3
Altman-Z 6.87
F-Score8
WACC7.92%
ROIC/WACC1.08
Cap/Depr(3y)244.4%
Cap/Depr(5y)271.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.61%
Profit Quality(5y)62.05%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.57%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
EPS Next Y16.45%
EPS Next 2Y14.56%
EPS Next 3Y13.42%
EPS Next 5Y12.12%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y6.02%
EBIT growth 1Y-1.77%
EBIT growth 3Y-7.94%
EBIT growth 5Y10.55%
EBIT Next Year64.69%
EBIT Next 3Y25.44%
EBIT Next 5Y18.21%
FCF growth 1Y133.64%
FCF growth 3Y-15.64%
FCF growth 5Y18.84%
OCF growth 1Y66.91%
OCF growth 3Y-6.83%
OCF growth 5Y10.34%

BIOMERIEUX / BIM.PA FAQ

What is the ChartMill fundamental rating of BIOMERIEUX (BIM.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA.


What is the valuation status of BIOMERIEUX (BIM.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to BIOMERIEUX (BIM.PA). This can be considered as Fairly Valued.


What is the profitability of BIM stock?

BIOMERIEUX (BIM.PA) has a profitability rating of 6 / 10.


Can you provide the financial health for BIM stock?

The financial health rating of BIOMERIEUX (BIM.PA) is 8 / 10.


How sustainable is the dividend of BIOMERIEUX (BIM.PA) stock?

The dividend rating of BIOMERIEUX (BIM.PA) is 3 / 10 and the dividend payout ratio is 28.04%.